NASDAQ:PETSPetmed Express Stock Price, Forecast & News

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PETS stock has increased by 25.4% and is now trading at $32.54.
View which stocks have been most impacted by COVID-19.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Petmed Express.

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, October 19th 2020.
View our earnings forecast for Petmed Express.

Petmed Express Inc (NASDAQ:PETS) issued its quarterly earnings results on Monday, July, 20th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by $0.01. The firm earned $96.20 million during the quarter, compared to the consensus estimate of $90.96 million. Petmed Express had a net margin of 9.41% and a return on equity of 21.91%. The firm's revenue was up 20.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.26 EPS.
View Petmed Express' earnings history.

Petmed Express announced a quarterly dividend on Monday, July 20th. Shareholders of record on Friday, July 31st will be given a dividend of $0.28 per share on Friday, August 7th. This represents a $1.12 annualized dividend and a yield of 3.44%. The ex-dividend date of this dividend is Thursday, July 30th.
View Petmed Express' dividend history.

2 brokerages have issued twelve-month price objectives for Petmed Express' shares. Their forecasts range from $20.00 to $31.00. On average, they expect Petmed Express' share price to reach $25.50 in the next twelve months. This suggests that the stock has a possible downside of 21.6%.
View analysts' price targets for Petmed Express.

Media coverage about PETS stock has been trending somewhat negative on Friday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Petmed Express earned a news sentiment score of -1.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term.
View the latest news about Petmed Express.

Petmed Express saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 5,350,000 shares, an increase of 27.4% from the April 30th total of 4,200,000 shares. Based on an average daily volume of 651,900 shares, the short-interest ratio is presently 8.2 days. Approximately 27.5% of the company's shares are sold short.
View Petmed Express' Short Interest.

Some companies that are related to Petmed Express include Amazon.com (AMZN), Netflix (NFLX), Booking (BKNG), Expedia Group (EXPE), Overstock.com (OSTK), Tripadvisor (TRIP), 1-800-Flowers.Com (FLWS), Shutterfly (SFLY), Groupon (GRPN) and U.S. Auto Parts Network (PRTS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Gilead Sciences (GILD), Alibaba Group (BABA), Cisco Systems (CSCO), Netflix (NFLX), Micron Technology (MU), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Petmed Express' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.12%), Prudential Financial Inc. (2.10%), Bank of New York Mellon Corp (1.82%), Robeco Institutional Asset Management B.V. (1.74%), Personal Capital Advisors Corp (1.51%) and ProShare Advisors LLC (1.19%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Robert C Schweitzer.
View institutional ownership trends for Petmed Express.

PETS stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Balyasny Asset Management LLC, Advisor Group Holdings Inc., Hancock Whitney Corp, Cairn Investment Group Inc., North Star Investment Management Corp., Principal Financial Group Inc., and Profit Investment Management LLC. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Gian Fulgoni, and Menderes Akdag.
View insider buying and selling activity for Petmed Express.

PETS stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Prudential Financial Inc., Robeco Institutional Asset Management B.V., ProShare Advisors LLC, Raymond James Financial Services Advisors Inc., Jefferies Group LLC, AJO LP, and Mackay Shields LLC.
View insider buying and selling activity for Petmed Express.

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PETS stock can currently be purchased for approximately $32.54.

Petmed Express has a market capitalization of $659.65 million and generates $284.13 million in revenue each year. Petmed Express employs 187 workers across the globe.

The official website for Petmed Express is www.1800petmeds.com.

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.